BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2006
View Archived Issues
COL-3 shows promise in AIDS-related Kaposi's sarcoma
Read More
Matuzumab/gemcitabine combination feasible in pancreatic cancer
Read More
Elemene inhibits laryngeal cancer cell growth
Read More
Activity of BXL-628 indicative of efficacy in overactive bladder
Read More
DDP-225 improves bladder irritation and capacity in animal models
Read More
IP-751 demonstrates efficacy against bladder irritation in vivo
Read More
Vertex begins clinical trial for potential cystic fibrosis treatment
Read More
Arginox continues to enroll TRIUMPH trial for cardiogenic shock
Read More
R-343 selected for advanced preclinical development as allergic asthma treatment
Read More
Neotropix's oncolytic virus candidate SVV-001 cleared for clinical trials
Read More
Biosite voluntarily withdraws PMA for Triage Stroke Panel
Read More
Amarin acquires rights to novel formulation of apomorphine
Read More
Agreement for preclinical testing of synDNA H5N1 avian flu vaccine candidates
Read More
Terumo and Yakult Honsha to codevelopment liposomal irinotecan
Read More
deCODE advances DG-031 to phase III for heart attack prevention
Read More
New spinout Cabrellis Pharmaceuticals begins operations
Read More
Collaboration to develop treatment for spinal muscular atrophy
Read More
Midway receives funding for gastrointestinal therapy development program
Read More
Peptech acquisition strengthens company's product pipeline
Read More
Health Canada approves Aromasin for adjuvant sequential therapy in early-stage breast cancer
Read More
Orion and Abbott consider continued development of levosimendan
Read More
Bristol-Myers Squibb discontinues muraglitazar development
Read More
Promising phase II results reported for leuprolide in Alzheimer's disease treatment
Read More
Therapeutic agents for respiratory disorders described in recent patents
Read More
Recent patents disclose new therapeutics for psychological disorders
Read More
Remicade approved as first biologic treatment for active pediatric Crohn's disease
Read More
Agents for arthritis and other inflammatory disorders reported
Read More
Prostaglandin D2 receptor 1 antagonist effective in reducing nicotinic acid-induced vasodilation
Read More